τεμιε ριιαιο
|
|
ων δϊψετδ αΰπβμιϊ: Polio Sabin.
ξητωιν ϊψετδ ΰηψϊ? λπρε μΰιπγχρ δϊψετεϊ »
|
|
 αρμ δαψιΰεϊ
φεψϊ ξϊο
PER OS
ξιπεο
Solution (oral)
ωιξεω αϊψετδ
For the active immunization of children and susceptible adults against poliomyelitis caused by the three types of polio viruses.
ξρτψ ψιωεν
057 14 27817 00
ιφψο
Glaxo Smith Kline Biologicals S.a
ϊεχσ ψιωιεο μϊψετδ
04/2012 - 04/2022
|
ηεξψ τςιμ
|
ψιλεζ / λξεϊ αιηιγϊ ξιπεο
|
| Poliovirus type 1 |
NLT 10^6.0 CCID50 |
| Poliovirus type 2 |
NLT 10^5.0 CCID50 |
| Poliovirus type 3 |
NLT 10^5.8 CCID50 |
|
ΰψιζδ
|
λξεϊ αΰψιζδ
|
ηιι ξγσ
|
ϊψετϊ ξψων
|
| Vial glass type i |
100 x 10 DOSES |
ηεγωιν 12 |
λο |
|
|
ΰεδαιν μωηχ αΰελμ?ξβεεο ξωηχι αιωεμ εΰτιιδ! μξωηχιν »
|
